Cargando…
Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study
INTRODUCTION: Patients with negative blood cultures (BCx) represent 85%–90% of all patients with BCx taken during hospital admission. This population usually includes a heterogeneous group of patients admitted with infectious diseases or febrile syndromes that require a blood culture. There is very...
Autores principales: | Jiménez-Jorge, Silvia, Palacios-Baena, Zaira R, Rosso-Fernández, Clara M, Girón-Ortega, José A, Rodriguez-Baño, Jesús, Retamar, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937003/ https://www.ncbi.nlm.nih.gov/pubmed/31857298 http://dx.doi.org/10.1136/bmjopen-2019-030062 |
Ejemplares similares
-
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project
por: Palacios-Baena, Zaira R, et al.
Publicado: (2020) -
Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol
por: Maldonado, Natalia, et al.
Publicado: (2023) -
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial
por: López-Cortés, Luis Eduardo, et al.
Publicado: (2017) -
Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
por: Rosso-Fernández, Clara, et al.
Publicado: (2015) -
Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol
por: Anaya-Baz, Blanca, et al.
Publicado: (2020)